Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
27 hedge funds and large institutions have $21.2M invested in Nuvation Bio Inc Warrants in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
25.41% more ownership
Funds ownership: 0% → 25.41% (+25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.79M |
| 2 |
6CM
683 Capital Management
New York
|
+$2.39M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$771K |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$771K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$771K |
Top Sellers
NUVB.WS Hedge Fund Activity: Q1 2021 in Review
27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q1 2021, worth a combined $21.2M.
Buyers outnumbered sellers: 27 funds opened new NUVB.WS positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $2.79M.
- 27 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $21.2M of Nuvation Bio Inc Warrants stock for Q1 2021.
- 27 funds opened new Nuvation Bio Inc Warrants positions in Q1 2021 and 0 closed out, a net change of +27 holders.
- The largest Nuvation Bio Inc Warrants buyer in Q1 2021 was EcoR1 Capital, an estimated $2.79M added.
Based on aggregated 13F filings for Q1 2021.